SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is under pressure as traders focus on rising borrowing costs, heavy debt and capital needs, and the risk that financing its AI data-center expansion could require further dilution. Bears question the businesss ability to manage those costs and warn of broader AI-infrastructure risks, while bulls argue contracted demand remains strong and the selloff is an overreaction.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Hot inflation and rising fuel costs, alongside debate over the Trump administrations Iran policy and Russian diesel arrangement, dominate discussion around DJT. Many traders are bearish and link the political and economic concerns to the stocks decline, while a smaller group sees the weakness as a buying opportunity.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Skydance Corp. - Ordinary Shares - Class B

The sharp selloff is centered on Skydances warrant distribution: shares are trading ex-warrant, and many traders view the decline as a mechanical separation of value, while others argue selling has pushed the stock down too far. Debate is compounded by concerns about dilution and the heavy debt assumed in the Warner Bros. Discovery acquisition.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

A sharp selloff across AI-infrastructure and neocloud stocks has put Nebius under pressure, with traders citing hot inflation and higher-rate concerns alongside questions about lofty valuations and the sectors debt- and capex-heavy data-center buildout. Bulls argue the pullback does not undermine AI-compute demand or Nebiuss business prospects, while bears see signs of a broader AI valuation reset and financing risk.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SOFI is drawing attention after a sharp selloff to new lows, with traders citing hot inflation readings, rising Treasury yields and renewed rate-hike concerns weighing on interest-sensitive fintech and bank stocks. The community is split between buyers calling the decline oversold and a dip-buying opportunity ahead of earnings, and bears warning that broken support and macro pressure could mean further losses; some also debate conflicting analyst ratings.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

LUNR is drawing attention amid a steep selloff that traders often link to weakness across space stocks, competition from SpaceX, and uncertainty around NASAs delayed CLPS 2.0 award. The debate pits buyers citing the companys backlog and lunar potential against bears focused on dilution, cash burn, and execution risks.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

SLV is drawing attention after a sharp selloff in silver, which traders largely attribute to rising Treasury yields and a stronger U.S. dollar weighing on precious metals. The discussion is mostly bearish about the near-term price action, though some investors are buying the dip and maintaining a longer-term silver-supply and inflation-hedge thesis; claims of deliberate price suppression remain speculation.

Bank of America Corp. is a bank and financial holding company, which engages in the provision of banking and nonbank financial services. It operates through the following segments: Consumer Banking, Global Wealth and Investment Management (GWIM), Global Banking, Global Markets, and All Other. The Consumer Banking segment offers credit, banking, and investment products and services to consumers and small businesses. The GWIM segment focuses on solutions to meet clients’ needs through a full set of investment management, brokerage, banking, and retirement products. The Global Banking segment deals with lending-related products and services, integrated working capital management and treasury solutions to clients, and underwriting and advisory services. The Global Markets segment includes sales and trading services, as well as research, to institutional clients across fixed-income, credit, currency, commodity, and equity businesses. The All Other segment consists of asset and liability management activities, equity investments, non-core mortgage loans and servicing activities, the net impact of periodic revisions to the mortgage servicing rights valuation model for both core and non-core MSRs, other liquidating businesses, residual expense allocations and other. The company was founded by Amadeo Peter Giannini in 1904 and is headquartered in Charlotte, NC.

Bank Of America Corp.

Bank of America Corp

Bank of Americas quarterly earnings and revenue miss, alongside a large regulatory penalty tied to anti-money-laundering and sanctions-compliance failures, drove the selloff. Traders debated whether the penalty is a one-off hit that overstates the damage or whether the earnings shortfall and compliance issues signal broader weakness; some viewed the drop as a buying opportunity.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastems early VS-7375 data showing activity across KRAS G12D-mutant cancers, especially pancreatic cancer, is driving attention and a sharp move in the shares. Traders are broadly encouraged by the results but caution that the cohorts are small, while debating whether the accompanying share offerings funding benefits outweigh dilution concerns.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas launch of Regna AI with Palantir, aimed at sovereign AI for defense missions and integration with Ondas autonomous systems, is driving the discussion. Bulls see potential to broaden the business beyond hardware, while skeptics question the ventures financial impact and dilution; many are frustrated that the shares weakened despite the announcement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Silence Therapeutics (SLN) Loses 28.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Silence Therapeutics (SLN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Silence Therapeutics (SLN) Upgraded to Buy: Here's Why

Silence Therapeutics (SLN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Silence Therapeutics to Participate in Three September Investor Conferences

Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing novel siRNA (short interfering RNA) therapies, today announced that management will participate in the following conferences and invited investors to participate by webcast. Cantor Global Healthcare...

Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters Option to Purchase Additional ADSs

Silence Therapeutics plc, (Nasdaq: SLN), (Silence or the Company), a global clinical-stage biotechnology company developing novel short interfering RNA (siRNA) therapies, today announced the closing of its previously announced underwritten public offering of 14,907,407 American Depositary Shares...

Wall Street Analysts Predict a 140.06% Upside in Silence Therapeutics (SLN): Here's  What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 140.1% in Silence Therapeutics (SLN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The Catalysts are Back: Socket Mobile Breaks Out While Biotechs Race Toward Major Milestones

Today's action is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with Socket Mobile (NASDAQ:SCKT) emerging as one of the session's standout movers while biotech names AbCellera Biologics (NASDAQ:ABCL), Silence Therapeutics (NASDAQ:SLN) and NeOnc Technologies (NASDAQ:NTHI) command attention around major clinical milestones.

Silence Therapeutics Says Blood Cancer Trial Delivers 'Best-Case Outcome'

Silence Therapeutics reports positive Phase 2 SANRECO trial data for divesiran in polycythemia vera. Phase 3 trial planned for 1H 2027.read more...

Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing novel siRNA (short interfering RNA) therapies, today announced positive topline results from the Phase 2 SANRECO trial of divesiran, a first-in-class siRNA, in 48 phlebotomy-dependent patients with...

Silence Therapeutics Hits the Catalyst Zone—Divesiran Data Could Send SLN Into Overdrive

Silence Therapeutics (NASDAQ:SLN) is heading into a potentially decisive moment as investors await topline results from the Phase 2 SANRECO trial of divesiran in polycythemia vera (PV). The company scheduled an August 10 conference call and webcast to discuss the results, putting its lead clinical program directly in the spotlight. With the Phase 2 study fully enrolled and topline data previously expected in the third quarter, the event represents a major potential inflection point for the clinical-stage biotech and its siRNA platform.

Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results

Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today reported its financial and business results for the second quarter ended June 30, 2026. Business Highlights Divesiran: First-in-class siRNA silencing TMPRSS6 for...

Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.

Silence Therapeutics Plc - ADR

Neutral Sentiment

Hotter than expected

As expected

Cooler than expected

The September Producer Price Index report lands Thursday, October 15 at 8:30 AM ET, one day after CPI, with August’s reading at 5.4% year over year, as investors look for clues on inflation before the Fed’s October 27-28 meeting. How will the September PPI print compare to consensus expectations? Vote and explain your reasoning in the comments.

How will the September PPI print compare to consensus expectations?

Current Price	$9.07
Prev Close	$8.87
Open	$8.86
Dividend Yield	0.00%
50-Day Moving Average	$12.45
Beta	0.90
Avg. Volume	863,603.22
PE Ratio	-7.01

52-Week High	$17.58
52-Week Low	$4.19
Market Capitalization	$551.31M
EPS (Annual)	-$1.88
Price to Book	10.89
Revenue Per Employee	$6,367.11

Feed

News

Sentiment

Earnings

Fundamentals

Info

SLN Fundamentals